Status:
UNKNOWN
Influence of DPP-4 on Inflammatory Parameters in Diabetics: Gender Aspects
Lead Sponsor:
Medical University of Vienna
Conditions:
Type 2 Diabetes Mellitus
Cardiovascular Risk
Eligibility:
All Genders
25-70 years
Brief Summary
Cardiovascular events are the most common cause for death in type 2 diabetes mellitus (T2DM) patients. Male diabetics have a 2 to 3 fold risk for cardiovascular disease (CVD) whereas female diabetes p...
Detailed Description
The World Health Organization (WHO) estimates that more than 180 million people worldwide have diabetes. This number is likely to more than double by 2030. Further, the WHO proclaims that diabetes cau...
Eligibility Criteria
Inclusion
- patients with T2DM
- metformin therapy
- HbA1c \< 7%
- 25 - 69 years
Exclusion
- pregnant women
- untreated thyroid dysfunction
- renal insufficiency (creatinine clearance \< 60 ml/min)
- unstable coronary heart disease
- NYHA III or IV
- severe hepatic dysfunction except steatosis (GOT and GPT three times higher than ULN)
- patients undergoing cortisone therapy
- condition post stroke within the last 6 months
Key Trial Info
Start Date :
January 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT01162772
Start Date
January 1 2010
Last Update
July 16 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical University of Viemma
Vienna, Austria, 1090